HealthSpring Assurance Rx (PDP)
Contract S5715, plan 034, segment 0 · offered by MEDCO CONTAINMENT LIFE & MEDCO CONTAINMENT NY & HEALTH CARE SERVICE CORPORATION · CMS PDP Region 13 (Michigan).
2027 drug-by-drug coverage is not published by CMS yet. The drug lookup covers 2026, whose formulary is live.
Renewed for 2027. CMS crosswalks 2026’s HealthSpring Assurance Rx (PDP) (S5617-221-0) into this plan, so its members move here unless they choose otherwise. See every 2026 → 2027 change.
Plan features
| Monthly premium | $9.30 |
|---|---|
| — basic (standard) part | $9.30 |
| — supplemental (enhanced) part | $0.00 |
| Annual deductible | $700.00 |
| Out-of-pocket threshold | $2,400.00 |
| Drug benefit type | Actuarially Equivalent Standard |
| $0 premium with full LIS | No |
| Premium with Extra Help (LIS) | $3.00 |
| LIS benchmark status | Above the regional benchmark |
| Formulary tiers | 5 |
| Formulary exception tier | 4 |
| Plan reach | National plan |
| Member services | (877)213-1817TTY 711 |
The plan’s own pages: Plan website · Formulary · Pharmacy directory
CMS star ratings
- Part D summary rating
- 2.5 out of 5 stars for Part D summary rating
Published per contract, which is how CMS scores them — every plan under contract S5715 shares this rating.
Formulary tiers — preferred pharmacy, initial coverage phase
| Tier | Cost-sharing |
|---|---|
| Tier 1 · Preferred Generic | 5% |
| Tier 2 · Generic | 10% |
| Tier 3 · Preferred Brand | 25% |
| Tier 4 · Non-Preferred Drug | 32% |
| Tier 5 · Specialty Tier | 25% |
Cost-sharing by coverage phase
| Tier | 30-day supply | 90-day supply | ||||
|---|---|---|---|---|---|---|
| Preferred | Standard | Mail Order | Preferred | Standard | Mail Order | |
| Initial coverage phase | ||||||
| Tier 1: Preferred Generic | 5% | 5% | 5% | 5% | 5% | 5% |
| Tier 2: Generic | 10% | 10% | 10% | 10% | 10% | 10% |
| Tier 3: Preferred Brand | 25% | 25% | 25% | 25% | 25% | 25% |
| Tier 4: Non-Preferred Drug | 32% | 32% | 32% | 32% | 32% | 32% |
| Tier 5: Specialty Tier | 25% | 25% | 25% | n/a | n/a | n/a |
These are the initial coverage phase amounts, as the plan filed them in its benefit package. The deductible and post-threshold phases are not stated per tier in that filing, so they are not shown here rather than being inferred; the plan's annual out-of-pocket threshold is $2,400.00.
Star rating measures
| Measure | 2027 | 2026 |
|---|---|---|
| DD1: Drug Plan Customer Service | ||
| Call Center – Foreign Language Interpreter and TTY Availability · D01 | 5 out of 5 stars for Call Center – Foreign Language Interpreter and TTY Availability | 4 out of 5 stars for Call Center – Foreign Language Interpreter and TTY Availability |
| DD2: Member Complaints and Changes in the Drug Plan’s Performance | ||
| Complaints about the Drug Plan · D02 | 4 out of 5 stars for Complaints about the Drug Plan | 4 out of 5 stars for Complaints about the Drug Plan |
| Members Choosing to Leave the Plan · D03 | 1 out of 5 stars for Members Choosing to Leave the Plan | 2 out of 5 stars for Members Choosing to Leave the Plan |
| Drug Plan Quality Improvement · D04 | not enough data | 1 out of 5 stars for Drug Plan Quality Improvement |
| DD3: Member Experience with the Drug Plan | ||
| Rating of Drug Plan · D05 | 1 out of 5 stars for Rating of Drug Plan | 1 out of 5 stars for Rating of Drug Plan |
| Getting Needed Prescription Drugs · D06 | 2 out of 5 stars for Getting Needed Prescription Drugs | 1 out of 5 stars for Getting Needed Prescription Drugs |
| DD4: Drug Safety and Accuracy of Drug Pricing | ||
| MPF Price Accuracy · D07 | 4 out of 5 stars for MPF Price Accuracy | 5 out of 5 stars for MPF Price Accuracy |
| Medication Adherence for Diabetes Medications · D08 | 2 out of 5 stars for Medication Adherence for Diabetes Medications | 2 out of 5 stars for Medication Adherence for Diabetes Medications |
| Medication Adherence for Hypertension (RAS antagonists) · D09 | 2 out of 5 stars for Medication Adherence for Hypertension (RAS antagonists) | 2 out of 5 stars for Medication Adherence for Hypertension (RAS antagonists) |
| Medication Adherence for Cholesterol (Statins) · D10 | 2 out of 5 stars for Medication Adherence for Cholesterol (Statins) | 2 out of 5 stars for Medication Adherence for Cholesterol (Statins) |
| Statin Use in Persons with Diabetes (SUPD) · D11 | 3 out of 5 stars for Statin Use in Persons with Diabetes (SUPD) | 3 out of 5 stars for Statin Use in Persons with Diabetes (SUPD) |
| Concurrent Use of Opioids and Benzodiazepines (COB) · D12 | 3 out of 5 stars for Concurrent Use of Opioids and Benzodiazepines (COB) | new measure |
| Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH) · D13 | 1 out of 5 stars for Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH) | new measure |
Measures are paired between the two years by name, not by the C/D number: CMS reuses those numbers, and in 2027 nineteen of them refer to a different measure than they did in 2026. A measure introduced for 2027 has no 2026 score to show. Published per contract — every plan under S5715 shares it.
Plan facts come from the CMS plan Landscape file and the CMS plan benefit package (PBP) files.